RA
CLB icon

Royce & Associates’s Core Laboratories CLB Stock Holding History

Royce & Associates’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-179,251
Closed -$3.01M – 766
2026
Q1 		$3.01M Sell
179,251
-27,465
-13% -$491K 0.03% 531
2025
Q4 		$3.31M Sell
206,716
-233,726
-53% -$3.48M 0.03% 529
2025
Q3 		$5.44M Sell
440,442
-331,918
-43% -$3.89M 0.05% 453
2025
Q2 		$8.9M Sell
772,360
-198,827
-20% -$2.36M 0.09% 321
2025
Q1 		$14.6M Buy
971,187
+2,059
+0.2% +$34.5K 0.16% 187
2024
Q4 		$16.8M Sell
969,128
-51,993
-5% -$1M 0.16% 186
2024
Q3 		$18.9M Buy
1,021,121
+84,022
+9% +$1.69M 0.17% 170
2024
Q2 		$19M Sell
937,099
-178,194
-16% -$3.15M 0.18% 162
2024
Q1 		$19M Buy
1,115,293
+201,019
+22% +$3.16M 0.17% 172
2023
Q4 		$16.1M Buy
914,274
+225,006
+33% +$4.53M 0.15% 192
2023
Q3 		$16.5M Buy
689,268
+72,476
+12% +$1.78M 0.17% 165
2023
Q2 		$14.3M Sell
616,792
-36,877
-6% -$834K 0.14% 207
2023
Q1 		$14.4M Sell
653,669
-85,094
-12% -$1.99M 0.14% 198
2022
Q4 		$15M Buy
+738,763
New +$14.3M 0.16% 177
2019
Q4 		– Sell
-77,500
Closed -$3.61M – 1143
2019
Q3 		$3.61M Buy
77,500
+2,500
+3% +$116K 0.03% 560
2019
Q2 		$3.92M Hold
75,000
– – 0.04% 550
2019
Q1 		$5.17M Buy
+75,000
New +$5.03M 0.04% 498
2015
Q3 		– Sell
-5,000
Closed -$570K – 1208
2015
Q2 		$570K Sell
5,000
-3,200
-39% -$388K ﹤0.01% 1073
2015
Q1 		$857K Hold
8,200
– – ﹤0.01% 1044
2014
Q4 		$987K Buy
+8,200
New +$1.08M ﹤0.01% 1075
2014
Q1 		– Sell
-100
Closed -$19K – 1420
2013
Q4 		$19K Sell
100
-17,600
-99% -$3.28M ﹤0.01% 1422
2013
Q3 		$3M Hold
17,700
– – 0.01% 970
2013
Q2 		$2.68M Buy
+17,700
New +$2.51M 0.01% 1001

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Royce & Associates's CLB Position: Q2 2026 in Review

Royce & Associates sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 179,251 shares — an estimated $3.01M sold.

Royce & Associates first reported a position in CLB in Q2 2013 and held it in 23 quarters. The position peaked at $19M in Q1 2024. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Royce & Associates reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
  • Royce & Associates sold 179,251 Core Laboratories shares in Q2 2026, an estimated $3.01M.
  • Royce & Associates first reported a position in Core Laboratories in Q2 2013 and held it in 23 quarters.
  • Royce & Associates's Core Laboratories position peaked at $19M in Q1 2024.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.